The American Journal of Human GeneticsGeneticsPeer-reviewed journal article
Mutation-specific pathophysiological mechanisms define different neurodevelopmental disorders associated with SATB1 dysfunction
Joery den HoediD, Elke de BoeriD, Norine VoisiniD, Alexander J.M. DingemansiD, Nicolas GuexiD, Laurens WieliD, Christoffer NellåkeriD, Shivarajan Manickavasagam Amudhavalli, Siddarth Banka, Frederique Sloan Bena, Bruria Ben‐ZeeviD, Vincent Robert BonaguraiD, Ange‐Line BrueliD, Theresa BrunetiD, Han G. BrunneriD, Hui Bein ChewiD, Jacqueline Chrast, Loreta Cimbalistienė, Hilary H CooniD, the DDD study, Emmanuèle C. DélotiD, Florence DémurgeriD, Anne‐Sophie Denommé‐PichoniD, C. Depienne, Dian Donnai, , Lisenka E.L.M. VissersiD
Abstract
Whereas large-scale statistical analyses can robustly identify disease-gene relationships, they do not accurately capture genotype-phenotype correlations or disease mechanisms. We use multiple lines of independent evidence to show that different variant types in a single gene, SATB1, cause clinically overlapping but distinct neurodevelopmental disorders. Clinical evaluation of 42 individuals carrying SATB1 variants identified overt genotype-phenotype relationships, associated with different pathophysiological mechanisms, established by functional assays. Missense variants in the CUT1 and CUT2 DNA-binding domains result in stronger chromatin binding, increased transcriptional repression and a severe phenotype. Contrastingly, variants predicted to result in haploinsufficiency are associated with a milder clinical presentation. A similarly mild phenotype is observed for individuals with premature protein truncating variants that escape nonsense-mediated decay and encode truncated proteins, which are transcriptionally active but mislocalized in the cell. Our results suggest that in-depth mutation-specific genotype-phenotype studies are essential to capture full disease complexity and to explain phenotypic variability.
- Citations
- 52
- FWCI
- 6.36
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Functional characterization of pathogenic SATB2 missense variants identifies distinct effects on chromatin binding and transcriptional activity
Joery den Hoed, Fleur Semmekrot, … Simon E. Fisher·Human Genetics and Genomics AdvancesPeer-reviewed·Oct 25, 2025
- SETBP1 variants outside the degron disrupt DNA-binding and transcription independent of protein abundance to cause a heterogeneous neurodevelopmental disorder
Maggie M. K. Wong, Rosalie A. Kampen, … Simon E. Fisher·medRxiv·Mar 4, 2022
- Delineating the molecular and phenotypic spectrum of the SETD1B-related syndrome
Marjolein J.A. Weerts, Kristina Lanko, … Tahsin Stefan Barakat·Genetics in MedicinePeer-reviewed·Aug 3, 2021
- Expanding the genotype and phenotype spectrum of SYT1-associated neurodevelopmental disorder
Holly Melland, Fabian Bumbak, … Kate Baker·Genetics in MedicinePeer-reviewed·Jan 28, 2022
- Dominant-negative mutations in CBX1 cause a neurodevelopmental disorder
Yukiko Kuroda, Aiko Iwata‐Otsubo, … Kosuke Izumi·bioRxiv·Sep 29, 2020
- Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1/GAT-1 variants
Dina Buitrago Silva, Marena I. Trinidad, … Arthur Wüster·medRxiv·Mar 9, 2022